Pavan Cheruvu, MD, has served as Sio’s President and Chief Executive Officer since February 2018. Prior to Sio, he served in a variety of roles at Roivant Sciences, including as Chief of Staff to the CEO and later on the executive team. A board-certified physician, Dr. Cheruvu completed his residency in internal medicine at Johns Hopkins Hospital and continued his training as a clinical fellow in cardiovascular medicine at the University of California, San Francisco. Dr. Cheruvu previously worked as a management consultant at McKinsey & Company, where he focused on R&D strategy and transformation for biopharmaceutical firms across North America, Asia, and Europe. Dr. Cheruvu graduated summa cum laude from Duke University, obtained a master’s degree from Oxford University as a Rhodes Scholar, and obtained his medical degree in a joint program between Harvard Medical School and M.I.T. He currently lives with his wife and daughter in New York City.